资讯

Join Moomintroll on his adventures with Snuffkin, Moominmamma, Moominpapa, Little My, Snork Maiden, and more as they enjoy all that life in Moomin Valley has to offer.
Will Merck's Keytruda Continue to Drive Growth Amid Looming LOE? June 10, 2025 — 09:46 am EDT. Written by Kinjel Shah for Zacks-> Merck MRK boasts more than six blockbuster drugs in its ...
Nonetheless, though Keytruda will lose patent exclusivity in 2028, its sales are expected to remain strong until then. Merck is also working on different strategies to drive Keytruda's long-term ...
A youth movement in Iowa is aiming to appeal to voters who have abandoned Democrats in the Trump era. There are pitfalls for people who grew up sharing everything online.
The community effort and attention around “Sinners,” a blockbuster horror movie, became an opportunity to talk about investing in the Delta town that built the blues.
Unpacking claim Brittney Griner faces WNBA suspension and $150K fine over Caitlin Clark comments Online users shared unproven claims that the WNBA was investigating Griner for allegedly making ...
Michael Wartella Photo: Tucker Bair. THE ELEPHANT MAN is a timeless examination of society’s perception of beauty, normalcy and kindness. At its heart is a deeply human story about the need for ...
Today we woke up to the news that, for the first time in her entire career, Taylor Swift now owns her own music. The singer made the announcement on her social media platforms by posting photographs ...
The settlement comes after a 15 year legal battle between the university and a Connecticut woman who claims she is a descendant of the people pictured.
Irish rap group Kneecap say they have been axed from the TRNSMT music festival in Glasgow over police concerns about safety. Police Scotland said last week that allowing the trio to perform at ...
Merck (NSE: PROR) & Co., Inc. (NYSE: MRK), a global healthcare giant known for its innovative pharmaceutical products, is navigating a complex landscape of opportunities and challenges.The company’s ...
With Keytruda accounting for a substantial portion of the company’s sales, the projected 10-20% decline post-LOE could create a substantial gap in Merck’s financial performance.